Policymakers and opinion leaders come together at the event hosted by Express Healthcare to discover a cure for the problems ailing the current public healthcare system.
‘Co-creating a Manifesto for a Healthy India’ was the theme for the second edition of Healthcare Sabha, – The National Thought Leadership Forum for Public Healthcare. Held at Novotel Varun Beach, in Visakhapatnam, Andhra Pradesh, recently, it started off with a welcome address by Viveka Roychowdhury, Editor, Express Healthcare. She took the audience through the vision of the event and welcomed them to three days of knowledge sharing through debates and discussions on various aspects of public health.
Knowledge sharing galore
Union Minister for Health Dr JP Nadda’s video message also awaited the participants of Healthcare Sabha 2017. He congratulated The Indian Express Group and Express Healthcare for creating a platform like Healthcare Sabha and highlighted the need for such events to facilitate constructive dialogues between the stakeholders in the arena of public health.
It was followed by an interesting panel discussion on a crucial topic which has severe adverse effects on India’s goal to ensure Universal Health Coverage to its citizens – talent crunch. Moderated by Dr Farhat Mantoo, Regional Coordinator HR, MSF, South Asia, the session boasted of an eminent panel comprising Prof AK Mahapatra, Chief, Neuroscience Centre, AIIMS, Delhi; Dr Madhumita Dobe, Director- Professor & Dean, All India Institute of Public Health (AIIPH); Sudeep Srivastava, Director, Pradhan Mantri Swasthya Suraksha Yojana (PMSSY); Dr Pravin Shingare, Director, Directorate of Medical Education & Research, Maharashtra; and Dr DK Sharma, Medical Superintendant, AIIMS. The panelists discussed the topic in detail and deliberated on the ways to mitigate the talent crunch, both in terms of capacity and competence in public health.
Bu hikaye Express Pharma dergisinin March 1, 2017 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Express Pharma dergisinin March 1, 2017 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Nutraceutical M&As: How strategic mergers are shaping the health and wellness market
The nutraceutical industry has seen a surge in M&A activity over the past three years as companies pursue strategic acquisitions to strengthen market positions, diversify offerings, and drive innovation. Sudhindran N, GM - Corporate Affairs, Nutrify Today explores key trends, motivations, notable deals, and future growth prospects shaping the industry
Rising research costs, complex drug systems, stringent regulations, and global pressures pose major threats to pharma R&D
According to one of the published reports, the pharma industry invested about $83 billion in R&D in 2019, which is about 10 times the research and development (R&D) spent per year in the 1980s, after adjusting for the effects of inflation.
Harnessing data analytics to propel drug discovery and development in 2025
As the pharma landscape evolves, data analytics will be at the forefront of drug discovery and development, transforming traditional methods. By leveraging data-driven insights, companies can expedite R&D, optimise clinical trials, and personalise treatments, bringing life-saving therapies to market more efficiently, explains Biju Davis, SVP, Engineering, Model N
Strengthening our presence within APAC through increased penetration is a key focus
Aanchal Tomar, Executive Director, Asia Pacific, Lonza Capsules Health Ingredients speaks about Lonza Capsules Health Ingredients’ strategic growth, challenges, and sustainability initiatives in the APAC market, showcasing their innovative capsule solutions and health ingredients that cater to the region's diverse pharmaceutical and nutraceutical needs, in an interview with Express Pharma
Responsible Sourcing and Manufacturing: Growing towards a sustainable future with Lonza
In response to the establishment of environmental impact targets by the pharmaceutical industry, Lonza promotes responsible sourcing practices, sustainable manufacturing standards, and renewable energy utilisation showcasing that responsible manufacturing can assist our customers to reach their sustainability goals, highlights Christine Lebeault, Head of Applied Sustainability, Lonza Capsules and Health Ingredients
Rethinking R&D to balance efficiency, innovation and sustainability
In an era of skyrocketing research costs and complex drug delivery challenges, pharma industry leaders share their insights on adopting advanced technologies, data-driven decision-making, and sustainable practices to optimise R&D and drive impactful therapies to market
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
